Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Estrella Immunopharma, Inc.

NASDAQ: ESLA · Life Sciences · 2 alerts · CIK 1844417

Share price
$0.3800Close, Nov 16
Market cap
$16.7M
Shares outstanding
43.97MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Estrella Immunopharma, Inc. filings on SEC EDGAR ↗

6:17 AM ET 10-Q
Financial Results

Estrella Immunopharma Q3 2026 Results: Net Loss of $7.38M, Loss Widens

Estrella Immunopharma reported a net loss of $11.98 million for the nine months ended September 30, 2026, compared to $12.45 million in the prior year period. The company's cash position decreased significantly to $92,458, while total stockholders' deficit widened to $13.97 million as research and development expenses remained the primary driver of operating costs.

Key figure
Net loss $7.38M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.